Latest Articles about AF

St. Jude's 1Q Earnings In Line - Analyst Blog

Zacks Equity Research — Wed, 17 Apr 2013 21:20:41 Z

St. Jude Medical 's ( STJ ) first-quarter adjusted earnings per share of 92 cents were in line with the Zacks Consensus Estimate and transcended the year-ago earnings of 86 cents.

Encouraging Results on ISIS Drug - Analyst Blog

Zacks Equity Research — Fri, 15 Mar 2013 01:47:39 Z

Isis Pharmaceuticals, Inc. ( ISIS ) recently announced encouraging results from a phase I study on its candidate, ISIS-CRP. In the study, ISIS-CRP demonstrated significant reduction of the

Milestone for St. Jude's ACP - Analyst Blog

Zacks Equity Research — Thu, 14 Mar 2013 18:15:26 Z

St. Jude Medical Inc. ( STJ ) has reached yet another important clinical landmark by registering the first implant of its Amplatzer Cardiac Plug (ACP) in a clinical trial. The ACP clinical

Bayer/JNJ's Xarelto in New Studies - Analyst Blog

Zacks Equity Research — Wed, 13 Mar 2013 00:10:31 Z

Bayer 's ( BAYRY ) Healthcare unit and its partner Johnson & Johnson ( JNJ ) recently initiated a phase III study (COMMANDER-HF) on Xarelto (rivaroxaban) in patients suffering

CE Mark for MDT's Performa Lead - Analyst Blog

Zacks Equity Research — Wed, 06 Mar 2013 19:55:04 Z

Medical Device major - Medtronic ( MDT ) recently won European CE Mark approval for its portfolio of Attain Performa Quadripolar leads. Following the approval, European launch of the same

Pipeline Advances at Isis Pharma - Analyst Blog

Zacks Equity Research — Fri, 01 Mar 2013 02:28:00 Z

Isis Pharmaceuticals, Inc. ( ISIS ) recently announced that it has initiated a phase II study (n = 20) to evaluate the safety and efficacy of its paroxysmal atrial fibrillation (AF)

Cardiome Selects Quintiles - Analyst Blog

Zacks Equity Research — Wed, 13 Feb 2013 02:58:01 Z

Cardiome Pharma Corp. ( CRME ) recently selected privately-held Quintiles for providing lifecycle safety and global regulatory affairs services for Brinavess (vernakalant intravenous). The

Astoria Financial Corporation (AF) Ex-Dividend Date Scheduled for February 13, 2013

NASDAQ.com News — Mon, 11 Feb 2013 19:00:04 Z

Astoria Financial Corporation ( AF ) will begin trading ex-dividend on February 13, 2013. A cash dividend payment of $0.04 per share is scheduled to be paid on March 01, 2013. Shareholders who

St. Jude Beats Estimates - Analyst Blog

Zacks Equity Research — Wed, 23 Jan 2013 22:14:39 Z

St. Jude Medical 's ( STJ ) fourth-quarter adjusted earnings per share of 92 cents topped the Zacks Consensus Estimate by 2 cents and transcended the year-ago earnings of 86 cents. The

CE Mark for St. Jude's Products - Analyst Blog

Zacks Equity Research — Tue, 22 Jan 2013 22:10:01 Z

St. Jude Medical ( STJ ) has received CE Mark approval for two of its devices viz. the AMPLATZER Amulet Left Atrial Appendage Occluder and the ViewFlex Xtra Intracardiac Echocardiography

Medtronic Expands AF Product Line - Analyst Blog

Zacks Equity Research — Fri, 18 Jan 2013 00:30:01 Z

Leading medical devices player, Medtronic ( MDT ) has strengthened its growing atrial fibrillation (AF) business. This is on account of the fact that it has received the U.S. Food and

St. Jude Reports Prelim 4Q Results - Analyst Blog

Zacks Equity Research — Tue, 15 Jan 2013 00:50:01 Z

Medical devices major, St. Jude Medical Inc. ( STJ ) released preliminary results for the 2012-fourth quarter. The company will report its financial results on Jan 23, before markets opens.

St. Jude Remains Neutral - Analyst Blog

Zacks Equity Research — Wed, 14 Nov 2012 03:30:01 Z

We reiterate our Neutral recommendation on St. Jude Medical ( STJ ). St. Jude reported third quarter 2012 adjusted earnings per share of 83 cents (up 6.4% year-over-year). The results also

Mixed 3Q for STJ, Outlook Revised - Analyst Blog

Zacks Equity Research — Thu, 18 Oct 2012 00:22:01 Z

Medical devices major, St. Jude Medical, Inc. 's ( STJ ) third quarter 2012 adjusted earnings of 83 cents per share beat the Zacks Consensus Estimate of 81 cents per share and surpassed the

Earnings Preview: St. Jude Medical - Analyst Blog

Zacks Equity Research — Tue, 16 Oct 2012 02:52:01 Z

Medical device major, St. Jude Medical ( STJ ) is slated to announce its third quarter results before the opening bell on Wednesday, October 17. The current Zacks Consensus Estimate for the